title: Effects of levosimendan on markers of kidney function in patients with acutely decompensated heart failure and renal impairment.
authors: aHeart Failure Unit, Second Department of Cardiology, Athens University Hospital 'Attikon' bBiochemical Department, General Hospital 'Evagelismos', Athens, Greece.
authors: Pinelopi
authors: P
authors: Rafouli-Stergiou
authors: John T
authors: JT
authors: Parissis
authors: Dimitrios
authors: D
authors: Farmakis
authors: Vassiliki
authors: V
authors: Bistola
authors: Alexandra
authors: A
authors: Frogoudaki
authors: Konstantinos
authors: K
authors: Vasiliadis
authors: Ignatios
authors: I
authors: Ikonomidis
authors: Ioannis
authors: I
authors: Paraskevaidis
authors: Dimitrios
authors: D
authors: Kremastinos
authors: Gerasimos
authors: G
authors: Filippatos
authors: John
authors: J
authors: Lekakis
mesh_terms: D015415:Biomarkers / Q000097:blood; D002316:Cardiotonic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D055316:Cystatin C / Q000097:blood*; D005260:Female; D006333:Heart Failure / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D006835:Hydrazones / Q000494:pharmacology / Q000627:therapeutic use*; D007668:Kidney / Q000187:drug effects*; D008297:Male; D011724:Pyridazines / Q000494:pharmacology / Q000627:therapeutic use*; D051437:Renal Insufficiency / Q000097:blood / Q000150:complications*; D000077464:Simendan
chemical_list: D015415:Biomarkers; D002316:Cardiotonic Agents; D055316:Cystatin C; D006835:Hydrazones; D011724:Pyridazines; D000077464:Simendan